Capvizr
THE DEAL, AT A GLANCE

InhalPlus

From the announcement
01Who is involvedBacked by NBank CapitalFrom the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
02What happenedInhalPlus raised Pre-Seed, announced 2026-11-06From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
03Why it mattersInhalPlus secured its first external investor through a €500,000 pre-seed investment from NBank Capital.From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗

InhalPlus · Financing Record

Explore source-linked visual explanations for InhalPlus. Unsupported claims are withheld while source review continues.

Record 15458 · Recorded date: 2026-11-06

What it does

InhalPlus: illustrative category image
Illustrative image (biotech lab), not InhalPlus's product · Stephane Lesbats (IFREMER, Pôle Images, Centre Bretagne - ZI / CC BY 4.0

Unsupported business claims are withheld pending source review. Explore the linked records for available evidence.

Open record 15458 →

Explore company records →
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime